In this sense, co-inhibition of MPS1 and NRF2 could lead to increased cell death through oxidative stress and thus the exploration of this combination could be of interest mainly for the treatment of HPV-negative HNSCC. This evidence concerns the gene NFE2L2 and head and neck squamous cell carcinoma.